ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

INZY Inozyme Pharma Inc

4.88
0.14 (2.95%)
07 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Inozyme Pharma Inc INZY 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.14 2.95% 4.88 07:29:01
개장가 저가 고가 종가 전일 종가
4.80 4.76 4.90 4.88 4.74
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202421:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
08/04/202419:30GLOBEInozyme Pharma Announces Positive Topline Data from Ongoing..
06/04/202407:00GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
02/04/202421:30GLOBEInozyme Pharma to Participate at the 23rd Annual Needham..
26/03/202421:30GLOBEInozyme Pharma to Report Topline Data from Ongoing Phase 1/2..
12/03/202421:30GLOBEInozyme Pharma Reports Full Year 2023 Financial Results and..
26/02/202422:30GLOBEInozyme Pharma to Participate in the TD Cowen 44th Annual..
14/02/202422:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202411:06EDGAR2Form SC 13D/A - General statement of acquisition of..
06/02/202422:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
05/12/202322:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
16/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
09/11/202322:30GLOBEInozyme Pharma to Participate in Upcoming Investor..
08/11/202306:07EDGAR2Form S-3 - Registration statement under Securities Act of..
07/11/202322:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:31EDGAR2Form 8-K - Current report
07/11/202322:30GLOBEInozyme Pharma Reports Third Quarter 2023 Financial Results..
04/11/202305:15GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
26/10/202321:30GLOBEInozyme Pharma Announces Presentation at the American..
10/10/202321:30GLOBEInozyme Pharma Highlights Inclusion of Generalized Arterial..
06/10/202321:30GLOBEInozyme Pharma Announces Three Poster Presentations at the..
04/10/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/09/202305:12EDGAR2Form 8-K - Current report
26/09/202320:30GLOBEInozyme Pharma Announces Positive Interim Data from Ongoing..
20/09/202321:30GLOBEInozyme Pharma to Host Virtual Investor and Analyst Event on..
06/09/202321:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
05/09/202321:30GLOBEInozyme Pharma to Present at the H.C. Wainwright 25th Annual..
12/08/202305:08EDGAR2Form SC 13D/A - General statement of acquisition of..
08/08/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202321:37EDGAR2Form 8-K - Current report
08/08/202321:30GLOBEInozyme Pharma Reports Second Quarter 2023 Financial Results..
08/08/202310:58EDGAR2Form SC 13D/A - General statement of acquisition of..
04/08/202309:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:01GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
02/08/202305:01GLOBEInozyme Pharma, Inc. Announces Closing of Public Offering of..
29/07/202306:19EDGAR2Form 8-K - Current report
29/07/202306:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/07/202312:20GLOBEInozyme Pharma, Inc. Announces Pricing of Public Offering of..
28/07/202306:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/07/202305:33GLOBEInozyme Pharma, Inc. Announces Proposed Offering of Common..
26/07/202320:42EDGAR2Form 8-K - Current report
26/07/202320:30GLOBEInozyme Pharma Announces Updates on Global Development..
19/07/202321:30GLOBEInozyme Pharma to Provide ENPP1 Deficiency Program Update on..
27/06/202321:30GLOBEInozyme Pharma Announces Dosing of First Infant with ENPP1..
02/06/202320:30GLOBEInozyme Pharma to Present at the Jefferies Healthcare..
09/05/202321:30GLOBEInozyme Pharma Reports First Quarter 2023 Financial Results..

최근 히스토리

Delayed Upgrade Clock